{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T14:29:00Z","timestamp":1726410540467},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1990]]},"DOI":"10.1007\/bf00685412","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T16:59:32Z","timestamp":1101661172000},"page":"S26-S29","source":"Crossref","is-referenced-by-count":13,"title":["Ifosfamide with and without Adriamycin in advanced uterine leiomyosarcoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Robert E.","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve","family":"Wiltshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine L.","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0277-5379(87)90075-7","volume":"23","author":"VHC Bramwell","year":"1987","unstructured":"Bramwell VHC, Mouridsen HT, Blackledge G, Somers R, Verwey J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, Van Oosterom A (1987) Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adults soft tissue sarcomas. Eur J Cancer Clin Oncol 23: 311","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0090-8258(83)90078-1","volume":"15","author":"EV Hannigan","year":"1983","unstructured":"Hannigan EV, Freedman RS, Elder KW, Rutledge FN (1983) Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide Gynecol Oncol 15: 224","journal-title":"Gynecol Oncol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0090-8258(84)90041-6","volume":"18","author":"MJ Marchese","year":"1984","unstructured":"Marchese MJ, Liskow AS, Crum CP, McCaffrey RM, Frick HC (1984) Uterine sarcomas: a clinicopathologic study, 1965?1981. Gynecol Oncol 18: 299","journal-title":"Gynecol Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0277-5379(86)90368-8","volume":"22","author":"CA Meanwell","year":"1986","unstructured":"Meanwell CA, Blake AE, Kelley KA, Honigsberger L, Blackledge G (1986) Prediction of ifosfamide\/mesna associated encephalopathy. Eur J Cancer Clin Oncol 22: 815","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/978-1-4757-1767-9_14","volume-title":"Pathology of the female genital tract","author":"HJ Norris","year":"1982","unstructured":"Norris HJ, Zaloudek CJ (1982) Mesenchymal tumors of the uterus. In: Pathology of the female genital tract, 2nd edn. Springer, Berlin Heidelberg New York, p 352","edition":"2nd edn"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E","volume":"52","author":"GA Omura","year":"1983","unstructured":"Omura GA, Mamor FJ, Blessing JA, Sedlacke TV, Thigpen JT, Creasman WT, Zaino RJ (1983) A randomized study of Adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52: 626","journal-title":"Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/1097-0142(197809)42:3<1152::AID-CNCR2820420319>3.0.CO;2-L","volume":"42","author":"OM Salazar","year":"1978","unstructured":"Salazar OM, Bonfiglio TA, Patten SF, Keller, BE, Feldstein M, Dunne ME, Rudolph J (1978) Uterine sarcomas: natural history, treatment and prognosis. Cancer 42: 1152","journal-title":"Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/1097-0142(197809)42:3<1161::AID-CNCR2820420320>3.0.CO;2-C","volume":"42","author":"OM Salazar","year":"1978","unstructured":"Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein ML, Dunne ME, Rudolph JH (1978) Uterine sarcomas: analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 42: 1161","journal-title":"Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-8140(84)80060-2","volume":"2","author":"DS Shimm","year":"1984","unstructured":"Shimm DS, Bell DA, Fuller AF, Bowling MC, Orlow EL, Munzenrider JE, Nelson JH, Ingersoll FM, Nikrui N, Donovan J (1984) Sarcomas of the uterine corpus: prognostic factors and treatment. Radiother Oncol 2: 201","journal-title":"Radiother Oncol"},{"key":"CR10","first-page":"1303","volume":"71","author":"RE Slayton","year":"1987","unstructured":"Slayton RE, Blessing JA, Angel C, Berman M (1987) Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study. Cancer Treat Rep 71: 1303","journal-title":"Cancer Treat Rep"},{"key":"CR11","first-page":"69","volume":"11","author":"RC Stuart-Harris","year":"1983","unstructured":"Stuart-Harris RC, Harper PG, Parsons CA, Kaye SB, Mooney CA, Gowing NF, Wiltshaw E (1983) High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma. Cancer Chemother Pharmacol 11: 69","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl","key":"CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF00647439","volume":"18","author":"E Wiltshaw","year":"1986","unstructured":"Wiltshaw E, Westbury G, Harmer C, McKinna A, Fisher C (1986) Ifosfamide plus mesna with and without Adriamycin in soft-tissue sarcoma. Cancer Chemother Pharmacol 18 [Suppl 2]: 10","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR13","volume-title":"WHO handbook for reporting results of cancer treatment","author":"World Health Organization","year":"1979","unstructured":"World Health Organization (1979) WHO handbook for reporting results of cancer treatment. Offset publication 48. WHO, Geneva"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00685412\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:10:24Z","timestamp":1554459024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00685412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"references-count":13,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1990]]}},"alternative-id":["BF00685412"],"URL":"https:\/\/doi.org\/10.1007\/bf00685412","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990]]}}}